Article
[Antitumor effects of gefitinib for metastatic brain tumors from lung carcinomas with EGFR mutation].
No shinkei geka. Neurological surgery - 1 Jun 2011
Ono Yasuhiro, Toyota Yasunori, Toyoshima Atsuhiko, Kuramoto Satoshi, Katzumata Atsushi, Kawauchi Masamitsu, Matsumoto Yuzo
Abstract excerpt
OBJECTIVE: Patients with lung cancer harboring epidermal growth factor receptor (EGFR) mutation respond remarkably well to tyrosine kinase inhibitors of the EGFR (EGFR-TKI). We examined the relation of the EGFR mutation and the efficacy of EGFR-TKI for metastatic brain tumors from lung cancer. MATERIALS AND METHODS: Forty-one patients with brain metastases from lung cancer were treated in our hospital from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
